Ibrutinib

Ibrutinib

SCHEMBL16887867

C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1.C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BTK

The experimentally established mechanism targets of Ibrutinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK known ✓ Q06187 15/20 0.93
EGFR P00533 9/20 0.90
BMX P51813 5/20 0.90
ITK Q08881 4/20 0.90
TEC P42680 3/20 0.90
HCK P08631 3/20 0.90
SRC P12931 3/20 0.90
BLK P51451 3/20 0.90
TXK P42681 2/20 0.90
LYN P07948 2/20 0.90
FGFR2 P21802 2/20 0.90
JAK3 P52333 2/20 0.90
NUDT5 Q9UKK9 2/20 0.90
RIPK2 O43353 1/20 0.90
NR1I2 O75469 1/20 0.90
SLC22A3 O75751 1/20 0.90
LATS1 O95835 1/20 0.90
NUDT14 O95848 1/20 0.90
ABL1 P00519 1/20 0.90
ERBB2 P04626 1/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15851228 0.96 BTK (1.00) BTKEGFRBMXITKTEC
SCHEMBL201601 0.96 BTK (1.00) BTKEGFRBMXITKTEC
SCHEMBL201600 0.96 BTK (1.00) BTKEGFRBMXITKTEC
Ibrutinib SCHEMBL201642 0.95 BTK (1.00) BTKEGFRBMXITKTEC
Ibrutinib SCHEMBL2244870 0.95 BTK (1.00) BTKEGFRBMXITKTEC
Ibrutinib SCHEMBL2244865 0.95 BTK (1.00) BTKEGFRBMXITKTEC
Ibrutinib SCHEMBL201641 0.95 BTK (1.00) BTKEGFRBMXITKTEC
Ibrutinib SCHEMBL201859 0.95 BTK (1.00) BTKEGFRBMXITKTEC
SCHEMBL21428758 0.92 BTK (0.95) BTKEGFRBMXITKTEC
SCHEMBL2158182 0.92 BTK (0.91) BTKEGFRBMXITKTEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079908-B2 Inhibitors of Bruton'S tyrosine kinase PHARMACYCLICS, INC. (US) 2015-07-14 US disclosed